US Patent Issued to CASI Pharmaceuticals on Oct. 7 for "Crystalline forms and formulations of a VCP/p97 inhibitor" (California Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,085, issued on Oct. 7, was assigned to CASI Pharmaceuticals Inc. (Rockville, Md.).

"Crystalline forms and formulations of a VCP/p97 inhibitor" was invented by Han-Jie Zhou (Foster City, Calif.) and Bing Yao (Millbrae, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are crystalline forms of 1-(4-(benzylamino)-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-2-yl)-2-methyl-1H-indole-4-carboxamide, and pharmaceutically acceptable salts and solvates thereof. Also described herein are pharmaceutical formulations of 1-(4-(benzylamino)-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-2-yl)-2-methyl-1H-indole-4-carboxamide, and pharmaceutically accept...